![]() Voyager Therapeutics Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS). | ![]() Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases. | |||
Founding Date | Founding Date 2020 | Founding Date 2014 | Founding Date 2017 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Dallas, US HQ | Locations Cambridge, US HQ | Locations Alachua, US HQ Alachua, US | Locations Philadelphia, US HQ |
Employees | Employees 5220% decrease | Employees 16230% increase | Employees 13 | Employees 20 |
Valuation ($) | Valuation ($) 385.3 m | Valuation ($) 382.8 m | Valuation ($) N/A | Valuation ($) 39.4 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $9.8m (FY, 2025) | Revenue (est.) $40.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($109m) (FY, 2025) | Net income ($119.7m) (FY, 2025) | Net income N/A | Net income ($45.5m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 125m | Total funding raised $ 135m | Total funding raised $ 30m | Total funding raised $ 225.5m |

Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS).
View company
Lacerta Therapeutics is a clinical stage gene therapy company.
View company
Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.
View company